Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Crops increasingly need to thrive in a broader range of conditions, including drought, salinity, and heat. Traditional plant ...
The startup aims to create a platform for treating extremely rare genetic mutations, armed with CRISPR advances and new regulatory pathways.
NYU Langone’s Advanced Rodent Transgenics Laboratory assists researchers in generating mutant mice for experimental use.
Leveraging modular gene editors and new regulatory pathways, Aurora will develop and commercialize therapies that can be rapidly tailored to many rare variants -- Founded by CRISPR pioneers Jennifer ...
Corporate presentation at 7:30 AM PST on January 15 in room Elizabethan A at the Westin St. Frances hotel, San Francisco ...
If I were to locate the moment AI slop broke through into popular consciousness, I’d pick the video of rabbits bouncing on a ...
The gene therapy success with Baby KJ, along with a new FDA program, have companies more interested in treating rare disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback